You searched for "PPE"
Characteristics of neuro-ophthalmic visual disturbances post-cataract surgery
The authors present a retrospective case review of adult patients seen by neuro-ophthalmology over a nine-year period. The aim of the study was to identify the cause of neuro-ophthalmic referrals within six months of cataract surgery. Individuals already known to...
Orbital fat density as a diagnostic tool in pre-septal and orbital cellulitis
This study aimed to evaluate the usefulness of orbital fat density in identifying post-septal involvement when initial differential diagnosis between orbital (OC) and periorbital (POC) cellulitis is unclear. This was a retrospective study of 57 patients with clinical diagnosis of...
Lean concept implementation process to improve clinic efficiency
The authors adopted a Lean concept to improve patient wait times, delays, clinic inefficiencies and patient satisfaction. They report the outcomes of implementation in this paper. Visit time, and patient and staff movements during patient examinations were mapped. Patient examinations...
Large vs. small posterior capsulotomy size and visual angle opacification rates
The purpose of this study was to assess the relationship between posterior capsulotomy size and significant visual angle opacification (VAO) in congenital and developmental cataract. This was a retrospective case control of children aged under seven years of age over...
Differences in strabismus surgery outcomes in preterm vs full-time birth infants
This study aimed to analyse motor and sensory outcomes of strabismus surgery in 70 preterm (group 1) and 242 full-term (group 2) infants. Group 1 mean gestational age and birth weight were 31.25 ±2.51 weeks and 1562.70 ±412.82g. Pre and...
Intra-arterial carboplatin therapy not associated with hearing loss
The aim of this study was to determine if administration of intra-arterial carboplatin (IAC) affected the hearing of children being treated for retinoblastoma. This was a prospective study in which 22 of 40 consented children completed therapy. Hearing was tested...
Oxymetazoline hydrochloride for improved symmetry in Graves’ disease
Oxymetazoline hydrochloride 0.1% ophthalmic solution has Food & Drug Administration (FDA) approval for use in involution ptosis. It is an alpha 1 agonist and partial alpha 2 agonist that stimulates Muller’s muscle to lift the lid. The authors of this...
